Cargando…
Protocol for the melatools skin self-monitoring trial: a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma
INTRODUCTION: Melanoma is the fifth most common cancer in the UK. Incidence rates have quadrupled over the last 30 years and continue to rise, especially among younger people. As routine screening of the general population is not currently recommended in the UK, a focus on secondary prevention throu...
Autores principales: | Mills, Katie, Emery, Jon, Lantaff, Rebecca, Radford, Michael, Pannebakker, Merel, Hall, Per, Burrows, Nigel, Williams, Kate, Saunders, Catherine L, Murchie, Peter, Walter, Fiona M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719271/ https://www.ncbi.nlm.nih.gov/pubmed/29187412 http://dx.doi.org/10.1136/bmjopen-2017-017934 |
Ejemplares similares
-
Effect of a Skin Self-monitoring Smartphone Application on Time to Physician Consultation Among Patients With Possible Melanoma: A Phase 2 Randomized Clinical Trial
por: Walter, Fiona M., et al.
Publicado: (2020) -
Protocol for the CHEST Australia Trial: a phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancer
por: Murray, Sonya R, et al.
Publicado: (2015) -
Dermoscopy for melanoma detection and triage in primary care: a systematic review
por: Jones, OT, et al.
Publicado: (2019) -
Who are the patients being offered the faecal immunochemical test in routine English general practice, and for what symptoms? A prospective descriptive study
por: Calanzani, Natalia, et al.
Publicado: (2022) -
Can we do better? A qualitative study in the East of England investigating patient experience and acceptability of using the faecal immunochemical test in primary care
por: Snudden, Claudia M, et al.
Publicado: (2023)